The Clinical Research Service is equipped with the most advanced technologies for the study of gene expression and the morphological analysis of cell cultures,. As part of its research activities on infectious agents, a Biosafety Level 3 (BSL-3) laboratory has been established, which is essential for the safe handling of high-risk pathogens. This laboratory has already enabled in-depth analyses of blood and serum samples from COVID-19 patients, making a significant contribution to the understanding of the immune response to the virus. Moreover, the facility serves as a strategic resource for the study of other emerging or re-emerging viral agents, supporting the development of new diagnostic and therapeutic strategies.
The system uses a computer-controlled air pump for the long-term cultivation of endothelial cells under physiological conditions, enabling the simulation of blood flow typical of different vascular districts. The system is equipped with slides that allow for an optimal experimental setup across various types of assays, making it compatible with downstream analysis techniques such as high-resolution microscopy, Western blotting, and PCR. Major applications include the study of the mechanobiological responses of the endothelium, analysis of cellular signaling mechanisms in response to flow, and research into vascular diseases such as atherosclerosis and endothelial inflammation.
The images display human endothelial cells derived from umbilical vein cultured in the absence (A) and presence (B) of flow, highlighting how the latter induces cellular alignment characteristic of the response to the shear stress exerted by blood on the endothelium.